PharmiWeb2h
Simulab Corporation Announces Promotion of Woody Salmonsen to Director of Sales, North America
In Response to Continued Growth, Simulab Corporation Adds Salmonsen to the Leadership Team SEATTLE, WASHINGTON / ACCESS ...
PharmiWeb3h
Black Book Research Identifies Top Global Growth Opportunities for openEHR Adoption in 2025
Cracking the Code on Interoperability with Scalable, Vendor-Neutral Architectures Powering AI-Ready Health Systems Worldwide ...
PharmiWeb3h
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
CHATHAM, NJ / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house ...
PharmiWeb1h
NLS Pharmaceutics and Kadimastem Announces Up to $3 Million Equity Financing and $25 Million Equity Facility Agreement
The equity financing is at a 10% premium to the market share price1 ZÜRICH, SWITZERLAND / ACCESS Newswire / March 31, 2025 / NLS Pharmaceutics Ltd.(NASDAQ:NLSP) ("NLS" or the "Company"), a Swiss ...
PharmiWeb1h
ONI's LNP Profiler Kit With AutoLNP: Revolutionizing Lipid Nanoparticle Characterization With Super-Resolution Microscopy
Setting a New Benchmark in Precision and Efficiency for LNP Analysis SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 31, 2025 / Oxford Nanoimaging (ONI), a leader in super-resolution microscopy, is ...
PharmiWeb2h
APONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out and merger planned
Annual Report/Annual ResultsAPONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out and merger planned 31.03.2025 / 14:00 CET/CESTThe issuer is solely ...
PharmiWeb1h
CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Business and Financial Results
BEIJING, CHINA / ACCESS Newswire / March 31, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...
PharmiWeb2h
Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or CNS Depression for Ultrapotent Opioid Exposure
Received positive feedback on New Drug Application submission via the 505(b)(2) pathway-Company leveraging existing human pharmacokinetic data with TH104-Advancing CMC plan to meet requirements of a ...
PharmiWeb2h
Aspira Receives $1.5 million Milestone Payment from the ARPA-H Sprint for Women’s Health Award
The Company Successfully Reaches the Second Milestone of ARPA-H $10 Million Award  AUSTIN, TX / ACCESS Newswire / March 31, 2025 / Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical ...
PharmiWeb2h
Ensysce Biosciences, Inc. Announces $1.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SAN DIEGO, CA / ACCESS Newswire / March 31, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for ...
PharmiWeb1h
International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results
SAN DIEGO, CA / ACCESS Newswire / March 31, 2025 / International Stem Cell Corporation (OTCQB:ISCO) ( ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing ...
PharmiWeb14h
ZetrOZ Systems to Showcase sam(R) Wearable Ultrasound Unit for Pro Football Trainers
During the PFATS meeting at the NFL Medical Summit, the inventors of sustained acoustic medicine will demonstrate the technology and present research showing its effectiveness in accelerating soft ...